Antagonistic Effect of Insertion/Deletion Polymorphism (HpaI) in the Regulatory Part of the Apolipoprotein CI Gene in Children with High and Low Plasma Cholesterol Levels;Protichůdny Efekt Inzerčního/delečního (HpaI) Polymorfizmu v Regulační Části Genu pro Apolipoprotein CI u Děti s Vysokou a Nízkou Hladinou Cholesterolu

Casopis Lekaru Ceskych

Volumn 143, Issue 2, 2004, Pages 94-96

  Hubáček, Jaroslav A ^a,b   Pistulkova H ^a   Skodova Z ^a   Lanska V ^a   Poledne, R ^a,b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Centrum Experimentalniho   (Czech Republic)

Author keywords

Apolipoprotein CI; Children; Cholesterol; DNA polymorphism

Indexed keywords

APOLIPOPROTEIN C1; CHOLESTEROL; LIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN C;

ALLELE; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; DNA POLYMORPHISM; GENE DELETION; GENE INSERTION; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; GENETICS; REGULATORY SEQUENCE;

APOLIPOPROTEIN C-I; APOLIPOPROTEINS C; CHILD; CHOLESTEROL; HUMANS; HYPERCHOLESTEROLEMIA; POLYMORPHISM, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 1442350491     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wu, L. L.: Review of risk factors for cardiovascular diseases. Ann. Clin. Lab. Sci., 1999, 29, s. 127-133.
2. Soutar, A. K.: Familial hypercholesterolaemia and LDL receptor mutations. J. Intern. Med., 1992, 231, s. 633-641.
3. Tybjaerg-Hansen, A.: Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100. Scand. J. Clin. Lab. Invest., 1995, 220 (Suppl.), s. 57-76.
4. Bodzioch, M., Orso, E., Klucken, J. et al.: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet., 1999, 22, s. 347-351.
5. Berge, K. E., Tian, H., Graf, G. A. et al.: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science, 2000, 290, s. 1771-1775.
6. Hubáček, J. A., Berge, K. E., Cohen, J. C., Hobbs, H. H.: Mutation in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum. Mutat., 2001, 18, s. 359-360.
7. Garcia, C. K., Wilund, K., Arca, M. et al.: Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science, 2001, 292, s. 1394-1398.
8. Scott, J., Knott, T. J., Shaw, D. J., Brook, J. D.: Localization of genes encoding apolipoproteins CI, CII, and E to the p 13 - cen region of human chromosome 19. Hum. Genet., 1985, 71, s. 144-146.
9. Jong, M. C., Hofker, M. H., Havekes, L. M.: Role of apoCs in lipoprotein metabolism. Functional differences between apoC1, apoC2 and apoC3. Arterioscler. Thromb. Vasc. Biol., 1999, 19, s. 472-484.
10. Frossard, P. M., Coleman, R. T., Malloz, M. J. et al.: Human apolipoprotein CI (apo CI) gene locus: Dra I dimorphic site. Nucleic Acids Res., 1987, 15, s. 1884.
11. Frossard, P. M., Lim, D. V., Coleman, R. T. et al.: Human apolipoprotein C1 (apo CI) gene locus: Bgl I dimorphic site. Nucleic Acids Res., 1987, 15, s. 1344.
12. Klasen, E. C., Talmud, P. J., Havekes, L. et al.: A common restriction fragment lenght polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidemia. Hum. Genet., 1987, 75, s. 244-247.
13. Smit, H., Kooij-Meijs, E., Woudt, L. P. et al.: Exact localization of the familial dysbeta lipoproteinemia associated Hpa I restriction site in the promoter region of the apo CI gene. Bioch. Bioph. Res. Com., 1988, 152, s. 1282-1288.
14. Xu, Y., Berglund, L., Ramakrishnan, R. et al.: A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J. Lipid Res., 1999, 40, s. 50-58.
15. Hubáček, J. A., Poledne, R.: Apolipoprotein E a jeho role v lipidovém metabolismu, kardiovaskulárních onemocněních a Alzheimerově chorobě. Prakt. Lék., 1998, 78, s. 105-108.
16. Hubáček, J. A., Pitha, J., Adámková, V. et al.: Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population. Almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms. Physiol. Res., 2003, 52, s. 195-200.
17. Pistulková, H., Poledne, R., Kaucká, J. et al.: Cholesterolaemia in school-age children and hypercholesterolaemia aggregation in the family. Cor Vasa, 1991, 33, s. 139-149.
18. Miller, S. A., Dykes, D. D., Polesky, H. F.: A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acid Res., 1988, 16, s. 1215.
19. Nillesen, W. M., Smeets, H. J. M., van Oost, B. A.: Human apo CI Hpa I restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acid Res., 1990, 11, s. 3428.
20. Davignon, J., Gregg, R. E., Sing, Ch. F.: Apolipoprotein E and atherosclerosis. Atherosclerosis, 1988, 8, s. 1-21.
21. Pennacchio, L. A., Olivier, M., Hubáček, J. A. et al.: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 2001, 294, s. 169-173.
22. Pennacchio, L. A., Olivier, M., Hubáček, J. A. et al.: Two independent apolipoprotein AV haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet., 2002, 11, s. 3031-3038.
23. Poledne, R., Hubáček, J., Píša, Z. et al.: Genetic markers in hypercholesterolemic and normocholesterolemic Czech children. Clin. Genet., 1994, 46, s. 88-91.
24. Hubáček, J. A., Pistulková, H., Valenta, Z., Poledne, R.: (TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolemia. VASA, 1999, 28, s. 169-171.
25. Hubáček, J. A., Pistulková, H., Š kodová, Z. et al.: Variability gene effect of apo All polymorphism in high-cholesterolemic children. Med. Sci. Monit., 1999, 5, s. 605-608.
26. Hubáček, J. A., Pistulková, H., Š kodová, Z. et al.: Polymorfismy v genech pro cholesterol ester transferový protein, apolipoprotein CIII a lipoproteinovou lipázu u dětí s nízkou a s vysokou hladinou cholesterolu. Čas. Lék. čes., 2001, 140, s. 79-81.
27. Hubáček, J. A., Pistulková, H., Š kodová, Z. et al.: Polymorfizmus v regulační části genu pro cholesterol 7α hydroxylázu u dětí s vysokou a nízkou hladinou cholesterolu. Čas. Lék. čes., 2003, 142, s. 423-426.
28. Hubáček, J. A., Pistulková, H., Š kodová, Z. et al.: Association between apolipoprotein B promotor haplotypes and cholesterol status. Ann. Clin. Biochem., 2001, 38, s. 399-400.
29. Hubáček, J.A., Pistulková, H., Škodová , Z. et al.: Lack of association of the Xbal polymorphism in the apolipoprotein B gene and cholesterolemia in childhood. Physiol. Res., 1998, 46, s. 89-93.